Prostate cancer Board decisions

The Veteran's claim for a compensable rating for prostate cancer residuals is remanded due to inadequate VA examinations. A new examination is needed to determine the extent of voiding dysfunction and current severity of prostate cancer.

The Veteran's initial compensable rating for erectile dysfunction, associated with prostate cancer, is denied as there is no evidence of penile deformity.

The Board denied the claim for service connection for the cause of the Veteran’s death, finding that his death was not caused or proximately due to his service-connected disabilities.

The Board has determined that the Veteran's prostate cancer is presumed to have been incurred as a result of service due to exposure to herbicide agents in Vietnam, and thus grants his claim for service connection.

The Veteran's bilateral hearing loss is granted as service-connected.,An initial rating in excess of 60 percent for prostate cancer residuals is denied.

The Board has decided to remand the case due to new evidence submitted after the August 2012 SOC, and the appellant did not waive RO consideration of this evidence.

The Board has remanded the Veteran's claim for service connection for a prostate disability, including prostate cancer, elevated prostate specific antigen, and low sperm count, to include as due to radiation exposure. The cause of the Veteran's death is also being remanded.

The Veteran's service-connected PTSD and prostate cancer disabilities prevent him from obtaining and maintaining substantially gainful employment, leading to a TDIU rating.

The Board denied service connection for prostate cancer, finding that the Veteran's duties did not routinely bring him on or near the perimeter of U-Tapao Royal Thai Air Force Base in Thailand. The evidence does not show regular contact with the perimeter and thus herbicide exposure is not shown. As a result, direct service connection cannot be established.

The Board has granted service connection for PTSD, but the claims for prostate cancer and thyroid disorder due to herbicide exposure are remanded. The claim for carpal tunnel is also remanded.

The Board has determined that the Veteran's death was caused by metastatic prostate cancer, which is a presumptive disability due to exposure to herbicide agents in Thailand. The evidence is at least in equipoise as to whether the Veteran was exposed to herbicide agents during his service.

The Veteran's prostate cancer is presumed to be due to herbicide exposure during his service in Thailand, and the claim for service connection is granted.

The Board has granted the Veteran's claim for service connection for prostate cancer, finding that there is a reasonable doubt in favor of the Veteran and resolving it in his favor. The decision is based on evidence showing a link between the Veteran's exposure to contaminated water at Camp Lejeune during active duty and his current diagnosis of prostate cancer.

The Veteran's claims for service connection are remanded due to the need for additional verification of his exposure to herbicide agents in Korea.

The Veteran's unspecified anxiety disorder resulting from the delayed notification of his prostate cancer diagnosis has been granted compensation under 38 U.S.C. § 1151.,The issue of additional disability due to the delay in notification and treatment for prostatic adenocarcinoma is remanded.

The Board denied a rating in excess of 20 percent for the Veteran's residuals of prostate cancer, finding that his condition did not meet the criteria for higher ratings based on voiding dysfunction or urinary frequency.

The Veteran's prostate cancer and erectile dysfunction are granted service connection, with the prostate cancer being presumed due to in-service herbicide exposure. The erectile dysfunction is secondary to the prostate cancer.

The Veteran's prostate cancer and erectile dysfunction are not service-connected, but the Board granted secondary service connection for erectile dysfunction due to a service-connected bladder cancer.

The Board denied the Veteran's claims for service connection for prostate cancer and skin cancer, finding that there was no evidence of herbicide exposure during service and insufficient medical evidence to establish a link between the cancers and service.

The Board denied an earlier effective date for the grant of service connection for prostate cancer, finding no evidence of a previously filed claim before January 22, 2019.